Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00173901
Status:
UNKNOWN
Last Update Posted:
2005-09-15
First Post:
2005-09-12
Brief Title:
Adverse Drug Reactions of Different Brands of Ceftazidime Injection
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Adverse Drug Reactions of Different Brands of Ceftazidime Injection
Status:
UNKNOWN
Status Verified Date:
2001-01
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug
Detailed Description:
Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns
The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug
The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None